Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report

Syam, Ari Fahrial and Miftahussurur, Muhammad and Makmun, Dadang and Abdullah, Murdani and Rani, Abdul Aziz and Siregar, Gontar Alamsyah and Simadibrata, Marcellus and Zubir, Nasrul and Dewa Nyoman Wibawa, I. and Purnomo, Hery Djagat and Manan, Chudahman and Djojoningrat, Dharmika and Fauzi, Achmad and Renaldi, Kaka and Maulahela, Hasan and Utari, Amanda Pitarini and Pribadi, Rabbinu Rangga and Muzellina, Virly Nanda and Nursyirwan, Saskia Aziza and Idrus, Muhammad Firhat and Ruswhandi, Ruswhandi and Sugihartono, Titong and Bestari, Muhammad Begawan and Bayupurnama, Putut and Pramana, Triyanta Yuli and Wibowo, Bogi Pratomo and Bakry, Achmad Fuad and Akil, Fardah and Parewangi, Andi Muhammad Luthfi and Widita, Haris and Mariadi, I Ketut and Murti, Ignatia Sinta and Yusuf, Ali Imron and Arles, Arles and Yusuf, Fauzi and Waleleng, Bradley Jimmy and Abimanyu, Abimanyu and Mulyadi, Yustar and Lucida, Maria Inge and Rezkhita, Yudith Annisa Ayu and Alfaray, Ricky Indra and Yamaoka, Yoshio (2023) Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report. Gut Pathogens, 15 (1). ISSN 17574749

[thumbnail of Management of dyspepsia and Helicobacter.pdf] Text
Management of dyspepsia and Helicobacter.pdf
Restricted to Registered users only
Download (1MB)

Abstract

Dyspepsia still becomes a major challenge in upper gastrointestinal disease in Indonesia. This disease often correlated with Helicobacter pylori infection. However, the prevalence of this bacterium is generally low in Indonesia. Therefore, several considerations should be taken into consideration during the management of dyspepsia and H. pylori infection. “Management of dyspepsia and H. pylori infection in Indonesia: The Indonesian consensus report” comprises information gathered from 22 gastroenterology centers across Indonesia. The experts gathered to evolve a consensus, that consists of the statements, grades of recommendations, evidence levels, and rationales for the dyspepsia and H. pylori infection management for daily clinical practice. The report explains several aspects from the updated epidemiology information to comprehensive management therapy. After the experts worked together on all statements in the recommendations, the results are presented with the final agreement as a consensus to help clinicians in understanding, diagnosing, and treating dyspepsia and H. pylori infection patients in daily clinical practice in Indonesia. © 2023, The Author(s).

Item Type: Article
Additional Information: Cited by: 0; All Open Access, Gold Open Access, Green Open Access
Uncontrolled Keywords: antibiotic agent; prokinetic agent; proton pump inhibitor; tetracyclic antidepressant agent; algorithm; biopsy; clinical practice; clinician; consensus; coronavirus disease 2019; cost effectiveness analysis; differential diagnosis; dyspepsia; endoscopy; gastroenterology; gastrointestinal disease; gastrointestinal endoscopy; gastrointestinal tract; health practitioner; Helicobacter infection; Helicobacter pylori; human; human tissue; idiopathic thrombocytopenic purpura; incidence; Indonesia; iron deficiency anemia; migraine; nonhuman; Parkinson disease; practice guideline; prevalence; publication bias; Review; stomach cancer; training; urea breath test; urticaria
Subjects: R Medicine > RB Pathology
Divisions: Faculty of Medicine, Public Health and Nursing > Public Health
Depositing User: Annisa Fitria Nur Azizah Annisa Fitria Nur Azizah
Date Deposited: 16 May 2024 01:30
Last Modified: 16 May 2024 01:30
URI: https://ir.lib.ugm.ac.id/id/eprint/1197

Actions (login required)

View Item
View Item